Semantics Relevance

Nvidia's AI ambitions in medicine and health care are becoming clear.

Logical Analysis Report (click to view);
Knowledge Map (click to view)
*Knowledge Map Navigation: Spatial co-ordinations are initially random, and will automatically re-arrange to minimize complexity based on distance between relationships. Mouse down and drag to pan. Right click on the strategic diagram toggles between motion and stationary. Hover over abstract node (orange) to view abstractions. Hover over leaf node to view corresponding narrative. Left click on the leaf node expands the narrative to view full text.

Knowledge Diagram Navigation:

Spatial co-ordinations are initially random, and will automatically re-arrange to minimize complexity based on distance between relationships. Mouse down and drag to pan. Right click on the strategic diagram toggles between motion and stationary. Hover over abstract node (orange) to view abstractions. Hover over leaf node to view corresponding narrative. Left click on the leaf node expands the narrative to view full text.

Narrative Analysis - Report

Key Focus

  • We have built deep domain expertise in healthcare over the past decade, creating the NVIDIA Clara healthcare platform and NVIDIA BioNeMo, a generative AI service to develop, customize and deploy AI foundation models for computer-aided drug discovery.'Last year, NVIDIA invested $50 million in Recursion for its drug discovery projects. ...
  • Over the last 18 months or so, we tend to believe it is more hope than hype because of the tangible outcomes and then the very compelling use cases how AI helped with the pharmaceutical industry, medtech industry or biotech industry,'said Arda Ural, EY Americas health and life sciences industry market leader ...
  • One of NVIDIA's greatest health-care strengths to date is the BioNeMo platform, a generative AI cloud service specifically made for drug development ...

    • Momentum supporting factors

  • (drug,generative,healthcare,service)
  • (drug,healthcare,service)
  • (drug,generative,healthcare,recursion)
  • (drug,generative,nvidia,recursion)
  • (drug,generative,recursion)
  • (drug,generative,service,recursion)
  • (drug,healthcare,recursion)
  • (drug,nvidia,recursion)
  • (drug,service,nvidia,recursion)
  • (drug,service,recursion)
  • (nvidia,models,recursion)
  • (nvidia,recursion)
  • (nvidia,service,generative,recursion)
  • (nvidia,service,recursion)
  • (drug,generative,healthcare,nvidia_clara)

    • Challenge supporting factors

  • (drug,cost,revenue)
  • (drug,cost,potential)
  • (nvidia,health,healthcare-focused,ai-powered)

    • Work-in-progress supporting factors

  • (drug,industry)
  • (drug,pharmaceutical,industry)
  • (nvidia,health,healthcare-focused,gtc_ai)
  • (drug,generative,service,nvidia)
  • (drug,generative,pharmaceutical)
  • (drug,cost,health)
  • (drug,cost,company)
  • (drug,cost,chip)
  • (drug,company,space)
  • (drug,company,health-care)
  • (drug,company,capital)
  • (drug,pharmaceutical,offshored)
  • (drug,pharmaceutical,medtech)
  • (drug,pharmaceutical,market)
  • (drug,pharmaceutical,manufacturing)

    • Time PeriodChallengeMomentumWIP
    Report2.86 54.94 42.20

    High Level Abstraction (HLA) combined

    High Level Abstraction (HLA)Report
    (1) (drug,industry)100.00
    (2) (drug,pharmaceutical,industry)99.67
    (3) (drug,generative,healthcare,service)99.01
    (4) (drug,healthcare,service)96.70
    (5) (drug,generative,healthcare,recursion)96.15
    (6) (drug,generative,service,nvidia)94.07
    (7) (drug,generative,nvidia,recursion)93.30
    (8) (drug,generative,recursion)89.89
    (9) (drug,generative,service,recursion)87.69
    (10) (drug,healthcare,recursion)87.03
    (11) (drug,nvidia,recursion)86.37
    (12) (drug,service,nvidia,recursion)85.27
    (13) (drug,service,recursion)84.84
    (14) (nvidia,models,recursion)84.51
    (15) (nvidia,recursion)83.96
    (16) (nvidia,service,generative,recursion)83.52
    (17) (nvidia,service,recursion)83.08
    (18) (drug,generative,healthcare,nvidia_clara)82.64
    (19) (drug,generative,nvidia,nvidia_clara)79.78
    (20) (drug,generative,nvidia_clara)76.70
    (21) (drug,generative,service,nvidia_clara)74.51
    (22) (drug,healthcare,nvidia_clara)73.63
    (23) (drug,nvidia,nvidia_clara)73.08
    (24) (drug,service,nvidia,nvidia_clara)72.09
    (25) (drug,service,nvidia_clara)71.54
    (26) (nvidia,models,nvidia_clara)71.32
    (27) (nvidia,service,generative,nvidia_clara)70.66
    (28) (nvidia,service,nvidia_clara)70.33
    (29) (drug,generative,healthcare,nvidia_bionemo)70.00
    (30) (drug,generative,nvidia,nvidia_bionemo)67.14
    (31) (drug,generative,nvidia_bionemo)64.18
    (32) (drug,generative,service,nvidia_bionemo)61.98
    (33) (drug,healthcare,nvidia_bionemo)60.99
    (34) (drug,nvidia,nvidia_bionemo)60.55
    (35) (drug,service,nvidia,nvidia_bionemo)59.56
    (36) (drug,service,nvidia_bionemo)58.79
    (37) (nvidia,models,nvidia_bionemo)58.68
    (38) (nvidia,service,generative,nvidia_bionemo)58.02
    (39) (nvidia,service,nvidia_bionemo)57.58
    (40) (drug,generative,healthcare,nvidia)57.36
    (41) (drug,healthcare,nvidia)52.64
    (42) (drug,generative,healthcare,models)51.87
    (43) (drug,generative,nvidia,models)48.90
    (44) (nvidia,health,healthcare-focused,gtc_ai)48.13
    (45) (drug,generative,service,models)46.04
    (46) (drug,healthcare,models)44.62
    (47) (drug,service,models)43.52
    (48) (drug,service,nvidia,models)43.30
    (49) (nvidia,service,generative,models)42.53
    (50) (nvidia,service,models)41.54
    (51) (nvidia,health,healthcare-focused,ai-powered)40.55
    (52) (drug,generative,pharmaceutical)37.14
    (53) (drug,cost,revenue)36.59
    (54) (drug,cost,potential)36.37
    (55) (drug,cost,health)36.15
    (56) (drug,cost,company)35.71
    (57) (drug,cost,chip)35.27
    (58) (drug,company,space)34.73
    (59) (drug,company,health-care)34.62
    (60) (drug,company,capital)34.40
    (61) (drug,service,nvidia,healthcare)33.85
    (62) (nvidia,models,healthcare)33.19
    (63) (nvidia,service,generative,healthcare)32.53
    (64) (nvidia,service,healthcare)32.31
    (65) (drug,pharmaceutical,offshored)32.20
    (66) (drug,pharmaceutical,medtech)32.09
    (67) (drug,pharmaceutical,market)31.98
    (68) (drug,pharmaceutical,manufacturing)31.87
    (69) (drug,pharmaceutical,health)31.76
    (70) (drug,pharmaceutical,finance)31.65
    (71) (drug,nvidia,schrdinger)30.88
    (72) (nvidia,technology,start)30.77
    (73) (technology,start)30.55
    (74) (nvidia,technology,raj_joshi)30.44
    (75) (technology,raj_joshi)30.22
    (76) (nvidia,technology,president)30.11
    (77) (technology,president)29.89
    (78) (nvidia,technology,plumbing)29.78
    (79) (technology,plumbing)29.56
    (80) (nvidia,technology,information)29.45
    (81) (technology,information)29.34
    (82) (nvidia,technology,cost)29.23
    (83) (nvidia,technology,analyst)29.12
    (84) (nvidia,health,ai-powered,johnson)28.90
    (85) (nvidia,health,gtc_ai,johnson)28.13
    (86) (nvidia,health,gtc_ai,ai-powered)27.47
    (87) (nvidia,health,healthcare-focused,johnson)27.36
    (88) (nvidia,health,johnson)26.70
    (89) (nvidia,healthcare-focused,ai-powered,johnson)26.48
    (90) (nvidia,healthcare-focused,gtc_ai,johnson)25.82
    (91) (nvidia,healthcare-focused,johnson)25.05
    (92) (nvidia,johnson)24.84
    (93) (nvidia,healthcare-focused,gtc_ai,ai-powered)22.42
    (94) (nvidia,health,ai-powered,revenue)17.03
    (95) (nvidia,health,gtc_ai,revenue)16.04
    (96) (nvidia,health,healthcare-focused,revenue)15.27
    (97) (nvidia,health,revenue)14.84
    (98) (nvidia,healthcare-focused,ai-powered,revenue)14.29
    (99) (nvidia,healthcare-focused,gtc_ai,revenue)13.52
    (100) (nvidia,healthcare-focused,revenue)13.08

    Back to top of page

    Supporting narratives:

    Please refer to knowledge diagram for a complete set of supporting narratives.

    • momentum - Back to HLA
      • 'We have built deep domain expertise in healthcare over the past decade, creating the NVIDIA Clara healthcare platform and NVIDIA BioNeMo, a generative AI service to develop, customize and deploy AI foundation models for computer-aided drug discovery.'Last year, NVIDIA invested $50 million in Recursion for its drug discovery projects ...
      • High Level Abstractions:
        • (drug,service,nvidia_bionemo)
        • (drug,generative,service,nvidia_bionemo)
        • (drug,generative,healthcare,nvidia_bionemo)
        • (drug,nvidia,nvidia_bionemo)
        • (drug,healthcare,nvidia)
        • (drug,generative,healthcare,service)
        • (drug,generative,healthcare,nvidia)
        • (drug,generative,service,nvidia_clara)
        • (nvidia,models,nvidia_bionemo)
        • (drug,healthcare,service)
        • (drug,generative,nvidia,nvidia_bionemo)
        • (drug,generative,healthcare,nvidia_clara)
        • (drug,generative,nvidia,nvidia_clara)
        • (drug,generative,nvidia_clara)
        • (drug,generative,healthcare,models)
        • (drug,healthcare,models)
        • (drug,service,nvidia,nvidia_clara)
        • (nvidia,service,nvidia_bionemo)
        • (drug,service,nvidia,nvidia_bionemo)
        • (drug,service,models)
        • (drug,generative,nvidia,models)
        • (drug,nvidia,nvidia_clara)
        • (drug,generative,service,models)
        • (nvidia,service,models)
        • (nvidia,service,healthcare)
        • (drug,service,nvidia_clara)
        • (nvidia,service,nvidia_clara)
        • (nvidia,service,generative,nvidia_bionemo)
        • (nvidia,service,generative,nvidia_clara)
        • (nvidia,models,drug)
        • (nvidia,models,healthcare)
        • (nvidia,service,generative,healthcare)
        • (drug,healthcare,nvidia_bionemo)
        • (nvidia,models,nvidia_clara)
        • (drug,healthcare,nvidia_clara)
        • (drug,service,nvidia,healthcare)
        • (drug,generative,nvidia_bionemo)
        • (nvidia,service,generative,models)
        • (drug,generative,service,nvidia)
        • (drug,service,nvidia,models)
        • Inferred entity relationships (50)
        • (drug,nvidia,recursion) [inferred]
        • (drug,generative,nvidia,service) [inferred]
        • (generative,nvidia,nvidia_bionemo,service) [inferred]
        • (drug,generative,healthcare,nvidia) [inferred]
        • (drug,healthcare,service) [inferred]
        • (drug,generative,recursion) [inferred]
        • (drug,nvidia,schrdinger) [inferred]
        • (generative,models,nvidia,service) [inferred]
        • (drug,generative,healthcare,models) [inferred]
        • (drug,nvidia,nvidia_bionemo) [inferred]
        • (drug,generative,nvidia,recursion) [inferred]
        • (drug,nvidia,recursion,service) [inferred]
        • (healthcare,models,nvidia) [inferred]
        • (drug,generative,nvidia_clara) [inferred]
        • (drug,nvidia,nvidia_bionemo,service) [inferred]
        • (generative,nvidia,recursion,service) [inferred]
        • (drug,generative,healthcare,nvidia_clara) [inferred]
        • (models,nvidia,nvidia_bionemo) [inferred]
        • (nvidia,nvidia_clara,service) [inferred]
        • (drug,models,nvidia,service) [inferred]
        • (drug,generative,models,service) [inferred]
        • (drug,generative,pharmaceutical) [inferred]
        • (drug,healthcare,nvidia) [inferred]
        • (nvidia,nvidia_bionemo,service) [inferred]
        • (drug,generative,nvidia_clara,service) [inferred]
        • (drug,generative,healthcare,nvidia_bionemo) [inferred]
        • (drug,generative,nvidia,nvidia_bionemo) [inferred]
        • (drug,models,service) [inferred]
        • (drug,generative,healthcare,service) [inferred]
        • (drug,healthcare,nvidia_clara) [inferred]
        • (drug,healthcare,recursion) [inferred]
        • (models,nvidia,service) [inferred]
        • (drug,generative,nvidia_bionemo,service) [inferred]
        • (drug,generative,nvidia_bionemo) [inferred]
        • (models,nvidia,recursion) [inferred]
        • (generative,nvidia,nvidia_clara,service) [inferred]
        • (drug,generative,nvidia,nvidia_clara) [inferred]
        • (drug,healthcare,nvidia_bionemo) [inferred]
        • (drug,nvidia,nvidia_clara,service) [inferred]
        • (drug,generative,recursion,service) [inferred]
        • (generative,healthcare,nvidia,service) [inferred]
        • (models,nvidia,nvidia_clara) [inferred]
        • (drug,generative,models,nvidia) [inferred]
        • (models,nvidia,train) [inferred]
        • (drug,healthcare,models) [inferred]
        • (drug,nvidia,nvidia_clara) [inferred]
        • (drug,generative,healthcare,recursion) [inferred]
        • (drug,models,nvidia) [inferred]
        • (drug,healthcare,nvidia,service) [inferred]
        • (healthcare,nvidia,service) [inferred]

    • momentum - Back to HLA
      • 'We have built deep domain expertise in healthcare over the past decade, creating the NVIDIA Clara healthcare platform and NVIDIA BioNeMo, a generative AI service to develop, customize and deploy AI foundation models for computer-aided drug discovery.'Last year, NVIDIA invested $50 million in Recursion for its drug discovery projects. ...
      • High Level Abstractions:
        • (nvidia,recursion)
        • (drug,generative,service,recursion)
        • (nvidia,models,recursion)
        • (drug,generative,nvidia,recursion)
        • (drug,generative,recursion)
        • (nvidia,service,recursion)
        • (drug,generative,healthcare,recursion)
        • (nvidia,service,generative,recursion)
        • (drug,service,recursion)
        • (drug,nvidia,recursion)
        • (drug,healthcare,recursion)
        • (drug,service,nvidia,recursion)
        • Inferred entity relationships (42)
        • (drug,nvidia,recursion) [inferred]
        • (drug,generative,nvidia,service) [inferred]
        • (generative,nvidia,nvidia_bionemo,service) [inferred]
        • (drug,generative,healthcare,nvidia) [inferred]
        • (drug,healthcare,service) [inferred]
        • (drug,generative,recursion) [inferred]
        • (drug,nvidia,schrdinger) [inferred]
        • (drug,generative,healthcare,models) [inferred]
        • (drug,nvidia,nvidia_bionemo) [inferred]
        • (drug,generative,nvidia,recursion) [inferred]
        • (drug,nvidia,recursion,service) [inferred]
        • (drug,generative,nvidia_clara) [inferred]
        • (drug,nvidia,nvidia_bionemo,service) [inferred]
        • (generative,nvidia,recursion,service) [inferred]
        • (drug,generative,healthcare,nvidia_clara) [inferred]
        • (models,nvidia,nvidia_bionemo) [inferred]
        • (drug,generative,models,service) [inferred]
        • (drug,generative,pharmaceutical) [inferred]
        • (drug,healthcare,nvidia) [inferred]
        • (drug,generative,nvidia_clara,service) [inferred]
        • (drug,generative,healthcare,nvidia_bionemo) [inferred]
        • (nvidia,recursion) [inferred]
        • (drug,generative,nvidia,nvidia_bionemo) [inferred]
        • (drug,generative,healthcare,service) [inferred]
        • (drug,healthcare,nvidia_clara) [inferred]
        • (models,nvidia,service) [inferred]
        • (drug,generative,nvidia_bionemo,service) [inferred]
        • (drug,generative,nvidia_bionemo) [inferred]
        • (generative,nvidia,nvidia_clara,service) [inferred]
        • (drug,generative,nvidia,nvidia_clara) [inferred]
        • (drug,healthcare,nvidia_bionemo) [inferred]
        • (nvidia,recursion,service) [inferred]
        • (drug,nvidia,nvidia_clara,service) [inferred]
        • (drug,generative,recursion,service) [inferred]
        • (generative,healthcare,nvidia,service) [inferred]
        • (models,nvidia,nvidia_clara) [inferred]
        • (drug,generative,models,nvidia) [inferred]
        • (models,nvidia,train) [inferred]
        • (drug,healthcare,models) [inferred]
        • (drug,nvidia,nvidia_clara) [inferred]
        • (drug,generative,healthcare,recursion) [inferred]
        • (drug,healthcare,nvidia,service) [inferred]

    • challenge - Back to HLA
      • For the AI chip leader, the move into health care is an effort that's been under development for a decade and has significant revenue potential. AI for drug discovery, a process that can take up to 12 years and cost billions, is being adopted quickly ...
      • High Level Abstractions:
        • (drug,cost,revenue)
        • (drug,cost,potential)
        • Inferred entity relationships (3)
        • (cost,drug,revenue) [inferred]
        • (cost,drug,potential) [inferred]
        • (cost,drug,health) [inferred]

    • challenge - Back to HLA
      • Nvidia's AI ambitions in medicine and health care are becoming clear.. ; NVIDIA launched about two dozen new AI-powered, healthcare-focused tools at its 2024 GTC AI conference last week, and deals with Johnson & Johnson and GE Healthcare for surgery and medical imaging ...
      • High Level Abstractions:
        • (nvidia,health,healthcare-focused,ai-powered)
        • Inferred entity relationships (10)
        • (ai-powered,health,johnson,nvidia) [inferred]
        • (ai-powered,health,nvidia,revenue) [inferred]
        • (health,healthcare-focused,nvidia,revenue) [inferred]
        • (healthcare-focused,nvidia,revenue) [inferred]
        • (health,healthcare-focused,non-tech,nvidia) [inferred]
        • (health,healthcare-focused,johnson,nvidia) [inferred]
        • (health,healthcare-focused,nvidia,opportunities) [inferred]
        • (ai-powered,health,non-tech,nvidia) [inferred]
        • (ai-powered,health,nvidia,opportunities) [inferred]
        • (healthcare-focused,nvidia,opportunities) [inferred]

    • WIP - Back to HLA
      • 'Over the last 18 months or so, we tend to believe it is more hope than hype because of the tangible outcomes and then the very compelling use cases how AI helped with the pharmaceutical industry, medtech industry or biotech industry,'said Arda Ural, EY Americas health and life sciences industry market leader ...
      • High Level Abstractions:
        • (drug,industry)
        • (drug,pharmaceutical,medtech)
        • (drug,pharmaceutical,industry)
        • Inferred entity relationships (2)
        • (drug,industry,pharmaceutical) [inferred]
        • (drug,industry) [inferred]

    • WIP - Back to HLA
      • One of NVIDIA's greatest health-care strengths to date is the BioNeMo platform, a generative AI cloud service specifically made for drug development ...
      • High Level Abstractions:
        • (drug,generative,service,nvidia)
        • Inferred entity relationships (21)
        • (drug,generative,healthcare,nvidia_bionemo) [inferred]
        • (drug,generative,recursion,service) [inferred]
        • (drug,generative,nvidia,nvidia_bionemo) [inferred]
        • (drug,generative,nvidia_clara) [inferred]
        • (generative,nvidia,nvidia_bionemo,service) [inferred]
        • (drug,generative,healthcare,nvidia) [inferred]
        • (drug,generative,models,nvidia) [inferred]
        • (drug,generative,recursion) [inferred]
        • (drug,generative,healthcare,service) [inferred]
        • (generative,nvidia,recursion,service) [inferred]
        • (drug,generative,healthcare,nvidia_clara) [inferred]
        • (drug,generative,nvidia_bionemo,service) [inferred]
        • (drug,generative,nvidia_bionemo) [inferred]
        • (drug,generative,healthcare,models) [inferred]
        • (drug,generative,healthcare,recursion) [inferred]
        • (drug,generative,models,service) [inferred]
        • (drug,generative,nvidia,recursion) [inferred]
        • (drug,generative,pharmaceutical) [inferred]
        • (generative,nvidia,nvidia_clara,service) [inferred]
        • (drug,generative,nvidia,nvidia_clara) [inferred]
        • (drug,generative,nvidia_clara,service) [inferred]

    • WIP - Back to HLA
      • Biotech-focused generative AI platforms have the ability to reduce costs for pharmaceutical companies beyond the drug development process. ...
      • High Level Abstractions:
        • (drug,generative,pharmaceutical)
        • Inferred entity relationships (18)
        • (drug,generative,healthcare,nvidia_bionemo) [inferred]
        • (drug,generative,nvidia,service) [inferred]
        • (drug,generative,recursion,service) [inferred]
        • (drug,generative,nvidia,nvidia_bionemo) [inferred]
        • (drug,generative,nvidia_clara) [inferred]
        • (drug,generative,healthcare,nvidia) [inferred]
        • (drug,generative,models,nvidia) [inferred]
        • (drug,generative,recursion) [inferred]
        • (drug,generative,healthcare,service) [inferred]
        • (drug,generative,healthcare,nvidia_clara) [inferred]
        • (drug,generative,nvidia_bionemo,service) [inferred]
        • (drug,generative,nvidia_bionemo) [inferred]
        • (drug,generative,healthcare,models) [inferred]
        • (drug,generative,healthcare,recursion) [inferred]
        • (drug,generative,models,service) [inferred]
        • (drug,generative,nvidia,recursion) [inferred]
        • (drug,generative,nvidia,nvidia_clara) [inferred]
        • (drug,generative,nvidia_clara,service) [inferred]

    • WIP - Back to HLA
      • For the AI chip leader, the move into health care is an effort that's been under development for a decade and has significant revenue potential ...
      • High Level Abstractions:
        • (drug,cost,health)
        • (drug,cost,chip)
        • Inferred entity relationships (4)
        • (cost,drug,revenue) [inferred]
        • (cost,drug,potential) [inferred]
        • (drug,health,pharmaceutical) [inferred]
        • (cost,drug,health) [inferred]

    • WIP - Back to HLA
      • 'So it's not only helping speed up the drug development, but also it helps with lowering the cost of running a company. ...
      • High Level Abstractions:
        • (drug,cost,company)
        • Inferred entity relationships (3)
        • (cost,drug,revenue) [inferred]
        • (cost,drug,potential) [inferred]
        • (cost,drug,health) [inferred]

    • WIP - Back to HLA
      • That means you can deploy more of the capital towards drug development and find more cures faster.'The health-care space is an example of how far a company that was designing gaming graphics cards a decade ago has come ...
      • High Level Abstractions:
        • (drug,company,space)
        • (drug,company,health-care)
        • (drug,company,capital)
        • Inferred entity relationships (2)
        • (company,drug,health-care) [inferred]
        • (company,drug,space) [inferred]

    • WIP - Back to HLA
      • Biotech-focused generative AI platforms have the ability to reduce costs for pharmaceutical companies beyond the drug development process. Many firms offshored their back office processes for supply chain, finance and administrative functions, as well as manufacturing, to save money ...
      • High Level Abstractions:
        • (drug,pharmaceutical,offshored)
        • (drug,pharmaceutical,finance)

    • WIP - Back to HLA
      • 'Over the last 18 months or so, we tend to believe it is more hope than hype because of the tangible outcomes and then the very compelling use cases how AI helped with the pharmaceutical industry, medtech industry or biotech industry,'said Arda Ural, EY Americas health and life sciences industry market leader. ...
      • High Level Abstractions:
        • (drug,pharmaceutical,market)
        • (drug,pharmaceutical,health)

    • WIP - Back to HLA
      • Many firms offshored their back office processes for supply chain, finance and administrative functions, as well as manufacturing, to save money. ...
      • High Level Abstractions:
        • (drug,pharmaceutical,manufacturing)

    • WIP - Back to HLA
      • The company has also worked with Roche's Genentech to develop new medications and better treatment protocols. It also partnered in 2021 with Schrdinger for drug discovery. . . One of NVIDIA's greatest health-care strengths to date is the BioNeMo platform, a generative AI cloud service specifically made for drug development ...
      • High Level Abstractions:
        • (drug,nvidia,schrdinger)
        • Inferred entity relationships (6)
        • (drug,nvidia,nvidia_clara,service) [inferred]
        • (drug,nvidia,recursion) [inferred]
        • (drug,nvidia,nvidia_bionemo,service) [inferred]
        • (drug,nvidia,nvidia_clara) [inferred]
        • (drug,nvidia,nvidia_bionemo) [inferred]
        • (drug,nvidia,recursion,service) [inferred]

    • WIP - Back to HLA
      • 'Let's say if you are a biotech firm, you take the full technology from Nvidia, and you just start working on it as opposed to figuring out 'how do I use this information technology.'' ...
      • High Level Abstractions:
        • (nvidia,technology,start)
        • (technology,start)
        • Inferred entity relationships (1)
        • (start,technology) [inferred]

    • WIP - Back to HLA
      • 'The reason why Nvidia is so popular today is because it basically provided the plumbing and the technology for something that you could not do simply before or if you had to do something like this you would need probably several times more time, money and cost,'said Raj Joshi, a technology analyst and senior vice president at Moody's Ratings ...
      • High Level Abstractions:
        • (nvidia,technology,raj_joshi)
        • (nvidia,technology,cost)
        • (technology,raj_joshi)
        • (nvidia,technology,plumbing)
        • (technology,plumbing)
        • Inferred entity relationships (2)
        • (raj_joshi,technology) [inferred]
        • (plumbing,technology) [inferred]

    • WIP - Back to HLA
      • 'The reason why Nvidia is so popular today is because it basically provided the plumbing and the technology for something that you could not do simply before or if you had to do something like this you would need probably several times more time, money and cost,'said Raj Joshi, a technology analyst and senior vice president at Moody's Ratings. ...
      • High Level Abstractions:
        • (nvidia,technology,president)
        • (nvidia,technology,analyst)
        • (technology,president)
        • Inferred entity relationships (1)
        • (president,technology) [inferred]

    • WIP - Back to HLA
      • 'Let's say if you are a biotech firm, you take the full technology from Nvidia, and you just start working on it as opposed to figuring out 'how do I use this information technology.''. ...
      • High Level Abstractions:
        • (nvidia,technology,information)
        • (technology,information)

    • WIP - Back to HLA
      • ; NVIDIA launched about two dozen new AI-powered, healthcare-focused tools at its 2024 GTC AI conference last week, and deals with Johnson & Johnson and GE Healthcare for surgery and medical imaging. ...
      • High Level Abstractions:
        • (nvidia,health,healthcare-focused,johnson)
        • (nvidia,healthcare-focused,ai-powered,johnson)
        • (nvidia,health,gtc_ai,medical)
        • (nvidia,johnson)
        • (nvidia,health,ai-powered,johnson)
        • (nvidia,health,johnson)
        • (nvidia,healthcare-focused,johnson)
        • (nvidia,healthcare-focused,gtc_ai,johnson)
        • (nvidia,healthcare-focused,gtc_ai,medical)
        • (nvidia,health,gtc_ai,johnson)
        • Inferred entity relationships (24)
        • (johnson,nvidia) [inferred]
        • (ai-powered,healthcare-focused,non-tech,nvidia) [inferred]
        • (ai-powered,healthcare-focused,nvidia,opportunities) [inferred]
        • (gtc_ai,healthcare-focused,medical,nvidia) [inferred]
        • (gtc_ai,health,medical,nvidia) [inferred]
        • (ai-powered,health,nvidia,revenue) [inferred]
        • (gtc_ai,healthcare-focused,non-tech,nvidia) [inferred]
        • (gtc_ai,health,johnson,nvidia) [inferred]
        • (gtc_ai,healthcare-focused,johnson,nvidia) [inferred]
        • (ai-powered,health,healthcare-focused,nvidia) [inferred]
        • (health,johnson,nvidia) [inferred]
        • (gtc_ai,health,non-tech,nvidia) [inferred]
        • (gtc_ai,health,nvidia,opportunities) [inferred]
        • (ai-powered,health,nvidia,opportunities) [inferred]
        • (gtc_ai,health,nvidia,revenue) [inferred]
        • (health,healthcare-focused,nvidia,revenue) [inferred]
        • (gtc_ai,healthcare-focused,nvidia,opportunities) [inferred]
        • (ai-powered,healthcare-focused,nvidia,revenue) [inferred]
        • (health,healthcare-focused,non-tech,nvidia) [inferred]
        • (health,healthcare-focused,nvidia,opportunities) [inferred]
        • (ai-powered,health,non-tech,nvidia) [inferred]
        • (gtc_ai,healthcare-focused,nvidia,revenue) [inferred]
        • (healthcare-focused,johnson,nvidia) [inferred]
        • (gtc_ai,health,healthcare-focused,nvidia) [inferred]

    • WIP - Back to HLA
      • ; NVIDIA launched about two dozen new AI-powered, healthcare-focused tools at its 2024 GTC AI conference last week, and deals with Johnson & Johnson and GE Healthcare for surgery and medical imaging ...
      • High Level Abstractions:
        • (nvidia,health,gtc_ai,ai-powered)
        • (nvidia,health,healthcare-focused,gtc_ai)
        • (nvidia,healthcare-focused,gtc_ai,ai-powered)
        • Inferred entity relationships (22)
        • (healthcare-focused,nvidia,revenue) [inferred]
        • (health,nvidia,opportunities) [inferred]
        • (ai-powered,gtc_ai,health,nvidia) [inferred]
        • (gtc_ai,healthcare-focused,medical,nvidia) [inferred]
        • (gtc_ai,health,medical,nvidia) [inferred]
        • (health,nvidia,revenue) [inferred]
        • (gtc_ai,healthcare-focused,non-tech,nvidia) [inferred]
        • (gtc_ai,health,johnson,nvidia) [inferred]
        • (gtc_ai,healthcare-focused,johnson,nvidia) [inferred]
        • (gtc_ai,health,non-tech,nvidia) [inferred]
        • (gtc_ai,health,nvidia,opportunities) [inferred]
        • (gtc_ai,health,nvidia,revenue) [inferred]
        • (health,healthcare-focused,nvidia,revenue) [inferred]
        • (gtc_ai,healthcare-focused,nvidia,opportunities) [inferred]
        • (health,healthcare-focused,non-tech,nvidia) [inferred]
        • (health,nvidia,technologies) [inferred]
        • (health,healthcare-focused,nvidia,opportunities) [inferred]
        • (gtc_ai,healthcare-focused,nvidia,revenue) [inferred]
        • (ai-powered,gtc_ai,healthcare-focused,nvidia) [inferred]
        • (health,healthcare-focused,johnson,nvidia) [inferred]
        • (gtc_ai,health,healthcare-focused,nvidia) [inferred]
        • (healthcare-focused,nvidia,opportunities) [inferred]

    • WIP - Back to HLA
      • The health care developments at its 2024 GTC AI conference , - which also included the launch of roughly two dozen new AI-powered, healthcare-focused tools - demonstrate just how important medicine is to Nvidia's non-tech sector revenue opportunities in the future ...
      • High Level Abstractions:
        • (nvidia,health,gtc_ai,ai-powered)
        • (nvidia,health,healthcare-focused,gtc_ai)
        • (nvidia,healthcare-focused,gtc_ai,ai-powered)
        • (nvidia,health,healthcare-focused,ai-powered)
        • Inferred entity relationships (26)
        • (healthcare-focused,nvidia,revenue) [inferred]
        • (health,nvidia,opportunities) [inferred]
        • (ai-powered,gtc_ai,health,nvidia) [inferred]
        • (gtc_ai,healthcare-focused,medical,nvidia) [inferred]
        • (gtc_ai,health,medical,nvidia) [inferred]
        • (health,nvidia,revenue) [inferred]
        • (ai-powered,health,nvidia,revenue) [inferred]
        • (gtc_ai,healthcare-focused,non-tech,nvidia) [inferred]
        • (gtc_ai,health,johnson,nvidia) [inferred]
        • (gtc_ai,healthcare-focused,johnson,nvidia) [inferred]
        • (gtc_ai,health,non-tech,nvidia) [inferred]
        • (gtc_ai,health,nvidia,opportunities) [inferred]
        • (ai-powered,health,nvidia,opportunities) [inferred]
        • (ai-powered,health,johnson,nvidia) [inferred]
        • (gtc_ai,health,nvidia,revenue) [inferred]
        • (health,healthcare-focused,nvidia,revenue) [inferred]
        • (gtc_ai,healthcare-focused,nvidia,opportunities) [inferred]
        • (health,healthcare-focused,non-tech,nvidia) [inferred]
        • (health,nvidia,technologies) [inferred]
        • (health,healthcare-focused,nvidia,opportunities) [inferred]
        • (ai-powered,health,non-tech,nvidia) [inferred]
        • (gtc_ai,healthcare-focused,nvidia,revenue) [inferred]
        • (ai-powered,gtc_ai,healthcare-focused,nvidia) [inferred]
        • (health,healthcare-focused,johnson,nvidia) [inferred]
        • (gtc_ai,health,healthcare-focused,nvidia) [inferred]
        • (healthcare-focused,nvidia,opportunities) [inferred]

    • WIP - Back to HLA
      • The health care developments at its 2024 GTC AI conference , - which also included the launch of roughly two dozen new AI-powered, healthcare-focused tools - demonstrate just how important medicine is to Nvidia's non-tech sector revenue opportunities in the future. ...
      • High Level Abstractions:
        • (nvidia,healthcare-focused,non-tech)
        • (nvidia,healthcare-focused,revenue)
        • (nvidia,healthcare-focused,ai-powered,opportunities)
        • (nvidia,health,healthcare-focused,opportunities)
        • (nvidia,healthcare-focused,gtc_ai,opportunities)
        • (nvidia,healthcare-focused,ai-powered,non-tech)
        • (nvidia,health,healthcare-focused,non-tech)
        • (nvidia,health,ai-powered,revenue)
        • (nvidia,health,revenue)
        • (nvidia,health,ai-powered,opportunities)
        • (nvidia,health,gtc_ai,opportunities)
        • (nvidia,healthcare-focused,opportunities)
        • (nvidia,healthcare-focused,gtc_ai,revenue)
        • (nvidia,health,ai-powered,non-tech)
        • (nvidia,health,opportunities)
        • (nvidia,health,gtc_ai,non-tech)
        • (nvidia,healthcare-focused,gtc_ai,non-tech)
        • (nvidia,health,gtc_ai,revenue)
        • (nvidia,health,healthcare-focused,revenue)
        • (nvidia,healthcare-focused,ai-powered,revenue)
        • Inferred entity relationships (30)
        • (healthcare-focused,nvidia,revenue) [inferred]
        • (ai-powered,healthcare-focused,non-tech,nvidia) [inferred]
        • (health,nvidia,opportunities) [inferred]
        • (health,nvidia,revenue) [inferred]
        • (gtc_ai,healthcare-focused,non-tech,nvidia) [inferred]
        • (gtc_ai,health,johnson,nvidia) [inferred]
        • (gtc_ai,healthcare-focused,johnson,nvidia) [inferred]
        • (ai-powered,health,johnson,nvidia) [inferred]
        • (gtc_ai,healthcare-focused,nvidia,opportunities) [inferred]
        • (health,healthcare-focused,nvidia,revenue) [inferred]
        • (health,healthcare-focused,nvidia,opportunities) [inferred]
        • (gtc_ai,healthcare-focused,nvidia,revenue) [inferred]
        • (ai-powered,healthcare-focused,johnson,nvidia) [inferred]
        • (healthcare-focused,nvidia,opportunities) [inferred]
        • (ai-powered,healthcare-focused,nvidia,opportunities) [inferred]
        • (gtc_ai,healthcare-focused,medical,nvidia) [inferred]
        • (gtc_ai,health,medical,nvidia) [inferred]
        • (ai-powered,health,nvidia,revenue) [inferred]
        • (ai-powered,health,healthcare-focused,nvidia) [inferred]
        • (gtc_ai,health,non-tech,nvidia) [inferred]
        • (gtc_ai,health,nvidia,opportunities) [inferred]
        • (ai-powered,health,nvidia,opportunities) [inferred]
        • (healthcare-focused,non-tech,nvidia) [inferred]
        • (gtc_ai,health,nvidia,revenue) [inferred]
        • (ai-powered,healthcare-focused,nvidia,revenue) [inferred]
        • (health,nvidia,technologies) [inferred]
        • (health,healthcare-focused,non-tech,nvidia) [inferred]
        • (ai-powered,health,non-tech,nvidia) [inferred]
        • (health,healthcare-focused,johnson,nvidia) [inferred]
        • (gtc_ai,health,healthcare-focused,nvidia) [inferred]

    • WIP - Back to HLA
      • 'This is a really unique feature we are seeing with AI that's being picked up much faster than other technologies.'The health care focus from Nvidia at its conference was a doubling down on an ambition it's had for a long time ...
      • High Level Abstractions:
        • (nvidia,health,technologies)
        • Inferred entity relationships (2)
        • (health,nvidia,revenue) [inferred]
        • (health,nvidia,opportunities) [inferred]

    • WIP - Back to HLA
      • Recursion is inputting its biological and chemical data to train NVIDIA's AI models on its cloud platform. The company has also worked with Roche's Genentech to develop new medications and better treatment protocols ...
      • High Level Abstractions:
        • (nvidia,models,train)
        • Inferred entity relationships (4)
        • (models,nvidia,nvidia_bionemo) [inferred]
        • (models,nvidia,service) [inferred]
        • (models,nvidia,nvidia_clara) [inferred]
        • (models,nvidia,recursion) [inferred]

    • WIP - Back to HLA
      • During an earnings call with investors in February, Nvidia mentioned several ways its technology was being adapted for the medical field. Companies like Recursion Pharmaceuticals. ...
      • High Level Abstractions:
        • (technology,medical)

    • WIP - Back to HLA
      • During an earnings call with investors in February, Nvidia mentioned several ways its technology was being adapted for the medical field ...
      • High Level Abstractions:
        • (technology,investors)